Home
News
-
Scottish funding for ELF-standard assay development
The Scottish Universities Life Sciences Alliance (SULSA) has established a fund to help Scottish academics develop ELF-standard assays for their dru -
EU Lead Factory publications are of high impact
According to the IMI Bibliometric report 2016, the scientific publication output from the EU Lead Factory is in top of its class, the 14 projects from IMI Call 5-11. -
European Lead Factory results make a real impact on IMI stakeholders
In September this year, the European Lead Factory (ELF) had the good fortune to highlight its achievements to the advisory groups of Innovative Medicines Initiative (IMI), ELF’s principal funding organisation. -
Neglected tropical disease project from i3S 1st Portuguese selected by European Lead Factory
The Parasite Disease Group, incorporated in the Institute for Research and Innovation in Health (i3S) and the Faculty of Pharmacy, University of Porto, is now joining the European research elite, as the first Portuguese team to introduce a project into the -
ELF: the talk of the international Medicinal Chemistry community at EFMC
European Lead Factory noticeably stated its presence during the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) that took place last week in Manchester, European City of Science 2016. -
Fundacíon Botín encourages its researchers to use the European Lead Factory
Fundacíon Botín encourages its researchers to use the European Lead Factory -
On the fast track to beat neglected tropical diseases
The European Lead Factory has lowered the hurdles for non-profit drug discovery programmes in the area of neglected tropical diseases (NTDs). -
First Polish drug target programme selected
A drug discovery programme involving an epigenetic target is the first drug target programme from Poland selected by the European Lead Factory. The selected drug target is a part of the oncology project developed by Selvita within its epigenetics platform. -
Bridging the Innovation Gap
The European Lead Factory is described as ‘bridging the innovation gap’ in a recent Careers Feature in the journal Nature. -
First Spanish programme selected
The first drug target programme from Spain has been selected by The European Lead Factory. It involves an epigenetic target against cancer that is being investigated by the Center for Applied Medical Research (CIMA) at the University of Navarra. -
Combinatorial library optimization process
The public part of Joint European Compound Library (JECL) is built using many small libraries (typically about 500 compounds per library) based around innovative scaffolds. -
Thirty partners - four years together in the lead
European Lead Factory General Assembly 2016 in Leiden, The Netherlands -
Nature Reviews Drug Discovery: ‘European Lead Factory hits its stride’
Today, Nature Reviews Drug Discovery published a News & Analysis article: ‘European Lead Factory hits its stride.’ -
IHL phase passes the thousand compounds mark for public programmes
Public target programmes that have received a promising Qualified Hit List (QHL) have the possibility to continue their collaboration with the European Lead Factory with the aim of producing an Improved Hit List (IHL). -
European Lead Factory has commenced a drug screening campaign for one of Effecta Pharma’s Dengue viral targets
"We are excited we can continue our initial collaboration with the EU Lead Factory and its European Screening Centre researchers in Oss, Oxford and Newhouse, which has yielded a screenable assay for one of the critical Dengue virus proteins.